Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 211

AutoDesk-backed eSub builds $12m series B

The construction management software provider secured $12m in a round led by growth equity investor Catalyst Investors.

May 31, 2019

Mudu.tv streams in Yonyou series B investment

Yonyou Network Technology has supplied $15.9m for the livestreaming services provider that will fund the development of AI and big data technology.

May 31, 2019

Crazy Dog retrieves series B funding

Fosun co-led a $43.4m round for omnichannel petcare brand Crazy Dog that will support an expansion slated to include the opening of offline stores.

May 30, 2019

Ayala aligns with corporates for $30m series B

The cancer drug developer has closed a series B round led by development partner Novartis that included Harel Insurance and Finance and SBI JI Innovation Fund.

May 30, 2019

Google returns for KaiOS in $50m series B

Existing backer Google has reinvested in the mobile operating system developer to increase its overall funding to $79m.

May 28, 2019

Cardinal Analytx ticks off $23m series B

GuideWell Mutual, Blue Shield California and existing backer Premera Blue Cross all invested in the healthcare prediction platform developer based on Stanford research.

May 28, 2019

AlloVir secures $120m funding allocation

The T-Cell therapy developer, based on research at Baylor College of Medicine, has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.

May 28, 2019

Corporate venturing deal net: 20-24 May 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

May 24, 2019

Pixie Dust cleans up with series B funding

Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.

May 24, 2019

AlloVir secures $120m funding allocation

The T-Cell therapy developer has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.

May 24, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here